Rogers Corporation: Q3 2012 Form 10-Q Summary
Business context and reporting period
Rogers Corporation is a global specialty materials manufacturer serving communications, automotive, transportation, defense, consumer electronics, and clean-technology markets. The filing covers the three and nine months ended September 30, 2012, compared with the corresponding 2011 periods. The Thermal Management Solutions segment was discontinued as of December 31, 2011, and comparative results were reclassified accordingly.
Key financial metrics
| Metric | Q3 2012 | Q3 2011 | 9M 2012 | 9M 2011 |
|---|---|---|---|---|
| Net sales | $130.2 million | $147.3 million | $378.3 million | $426.8 million |
| Gross margin | $43.0 million; 33.0% | $50.7 million; 34.4% | $116.3 million; 30.7% | $141.9 million; 33.2% |
| Operating income | $10.1 million; 7.8% | $17.9 million; 12.2% | $18.5 million; 4.9% | $47.7 million; 11.2% |
| Income from continuing operations | $59.0 million | $15.7 million | $63.7 million | $40.2 million |
| Diluted EPS from continuing operations | $3.46 | $0.93 | $3.77 | $2.40 |
| Cash flow from operating activities | Not separately provided | Not separately provided | $15.5 million | $(2.7) million |
Reported Q3 net income was $59.0 million, or $3.46 diluted EPS, versus $14.4 million, or $0.85 diluted EPS, in Q3 2011. The significant increase primarily reflects approximately $50.0 million of discrete tax benefits, principally the reversal of a valuation allowance on U.S. deferred tax assets, rather than underlying operating improvement.
At September 30, 2012, cash and cash equivalents were $91.1 million, compared with $79.7 million at December 31, 2011. Accounts receivable were $88.6 million and inventories were $70.1 million, down from $78.3 million at year-end. Total debt under credit facilities was $106.0 million, consisting of $92.5 million of term debt and $13.5 million of revolver borrowings. The company also had an $8.4 million capital lease obligation.
The company reported $15.5 million of operating cash flow for the first nine months, $7.9 million of cash provided by investing activities, and $9.7 million of cash used in financing activities. Capital expenditures were $16.5 million. Cash generation benefited from liquidation of auction-rate securities for $25.4 million, while cash uses included $16.0 million of pension contributions, debt repayments, and approximately $6.3 million paid under the former CEO’s pension restoration arrangement.
Material changes versus the prior comparable period
- Sales declined 11.6% in Q3 and 11.4% for the first nine months, primarily because of weakness in Curamik Electronics Solutions and Power Distribution Systems.
- Q3 gross margin declined 140 basis points and nine-month gross margin declined 250 basis points, reflecting lower volume, inventory-related effects, and restructuring charges.
- Q3 operating income declined 43.6%; nine-month operating income declined 61.2%. Restructuring and impairment charges were $1.8 million in Q3 and $10.0 million year to date, compared with none in the 2011 periods.
- High Performance Foams sales declined 3.5% in Q3, while Printed Circuit Materials sales increased 1.0%. Curamik sales declined 40.0% and Power Distribution Systems sales declined approximately 16.8%.
- Curamik shifted from $4.1 million of operating income in Q3 2011 to a $2.4 million operating loss in Q3 2012. For the first nine months, Curamik shifted from $7.3 million of operating income to a $5.4 million operating loss.
- Debt declined from $122.5 million at December 31, 2011 to $106.0 million at September 30, 2012. Pension liability declined from $68.9 million to $46.5 million, primarily due to pension contributions and settlement activity.
- The company liquidated its remaining auction-rate securities, recording a $3.2 million realized loss and eliminating the $26.0 million long-term marketable-securities balance held at year-end 2011.
Guidance, outlook, risks, contingencies, and unusual items
Management projected an effective tax rate of approximately 25% for the remainder of 2012. It expected near-term R&D spending to remain approximately 3.5% to 4.0% of sales. Management stated that it expected liquidity and operating cash flows, together with available credit, to fund operations, capital expenditures, R&D, debt service, and other needs for at least the next twelve months.
Management expects continued benefits from streamlining initiatives. The company initially targeted approximately $13.0 million of annualized savings by the fourth quarter of 2012 and reported Q3 savings of approximately $4.5 million versus a quarterly target of $3.0 million. The Bremen, Germany facility shutdown was expected to be substantially completed by early 2013, and Curamik final-inspection operations were expected to move from Germany to Hungary in 2013. Related Curamik reduction-in-force and startup costs had not been reliably estimated.
The principal operating risk is continued weakness in European and Chinese infrastructure, transportation, wind-energy, and industrial markets. Additional risks include foreign-exchange volatility, raw-material pricing, customer inventory corrections, debt covenant compliance, pension obligations, potential goodwill impairment, environmental matters, asbestos litigation, and uncertain insurance recoveries.
Curamik’s interim goodwill impairment test found that estimated fair value exceeded carrying value by approximately 14.6%; a 10% fair-value decline would reduce the excess to approximately 3.1%. The test depended on forecasts including a 14% discount rate, 3% terminal growth rate, projected sales growth, and margin improvement. Failure to achieve those assumptions could result in future impairment charges.
Asbestos-related claims increased to 315 pending claims at September 30, 2012, from 242 at December 31, 2011. The company’s estimated asbestos liability and related insurance receivable for the five-year period through 2016 were $27.9 million and $27.7 million, respectively. Management stated that actual costs and recoveries could differ materially from estimates. The current insurance cost-sharing agreement expires January 25, 2015.
Important facts for investors to verify
- Separate the $50.0 million discrete tax benefit from recurring earnings and assess the realizability of deferred tax assets.
- Monitor Curamik and Power Distribution Systems for evidence of volume recovery and operating-margin improvement.
- Assess whether restructuring savings are sustainable and compare them with remaining shutdown, relocation, severance, and startup costs.
- Review debt-amortization requirements, variable-rate exposure, the interest-rate swap, and covenant headroom. Q3 leverage was approximately 1.55x versus a 3.0x limit, and fixed-charge coverage was 1.93x versus a 1.25x minimum.
- Evaluate goodwill impairment sensitivity for Curamik, particularly if projected growth or margin improvement fails to materialize.
- Track asbestos claim activity, insurance coverage and cost-sharing arrangements, including the approaching January 2015 agreement expiration.
- Reconcile cash-flow disclosures: the financial statements report $15.5 million of nine-month operating cash flow, while one MD&A table presents a different continuing-operations comparative figure for 2011; the filing text should be reviewed for the precise comparative presentation.